99 related articles for article (PubMed ID: 8753056)
1. [Peripheral blood stem cell transplantation].
Harada M
Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):886-91. PubMed ID: 8753056
[No Abstract] [Full Text] [Related]
2. Bone marrow and peripheral blood stem cell transplantation for malignancy.
Johnson PW; Simnett SJ; Sweetenham JW; Morgan GJ; Stewart LA
Health Technol Assess; 1998; 2(8):1-187. PubMed ID: 9728295
[No Abstract] [Full Text] [Related]
3. Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD.
Viret F; Chabannon C; Aurran-Schleinitz T; Reviron D; Stoppa AM; Faucher C; Ladaique P; Gastaut JA; Maraninchi D; Blaise D
Bone Marrow Transplant; 1999 Jul; 24(2):225-7. PubMed ID: 10455358
[No Abstract] [Full Text] [Related]
4. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
5. [Clinical use of peripheral stem cells for autologous transplantation].
Zingsem J; Zeiler T; Weisbach V; Holfeld-Ozuysal C; Zimmermann R; Heuft HG; Beyer J; Schwerdtfeger R; Eckstein R
Beitr Infusionsther; 1991; 28():251-3. PubMed ID: 1725632
[TBL] [Abstract][Full Text] [Related]
6. The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer.
Appelbaum FR
CA Cancer J Clin; 1996; 46(3):142-64. PubMed ID: 8646545
[TBL] [Abstract][Full Text] [Related]
7. [Current status of allogeneic-peripheral blood stem cell transplantation and the possibility for unrelated donor-peripheral blood stem cell transplantation].
Shinagawa K; Harada M
Rinsho Ketsueki; 1998 May; 39(5):342-4. PubMed ID: 9637881
[No Abstract] [Full Text] [Related]
8. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
[No Abstract] [Full Text] [Related]
9. Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer.
de Arriba F; Corral J; Ayala F; Heras I; Moraleda JM; Osma MM; González-Conejero R; Ortuño F; Vicente V
Bone Marrow Transplant; 1999 Mar; 23(6):621-4. PubMed ID: 10217194
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
Michallet M; Dhedin N; Michallet AS
Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
[TBL] [Abstract][Full Text] [Related]
11. [Current status and issues in hematopoietic stem cell transplantation].
Harada M
Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
[No Abstract] [Full Text] [Related]
12. [Lung complications of hematopoietic stem cell transplantation].
Philit F; Cordonnier C; Michallet M; Cordier JF
Rev Mal Respir; 1996 Nov; 13(5 Suppl):S71-84. PubMed ID: 9011914
[TBL] [Abstract][Full Text] [Related]
13. Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease.
Ringdén O; Lönnqvist B; Hägglund H; Ljungman P; Shanwell A; Lawlor E; Schmitz N
Bone Marrow Transplant; 1995 Dec; 16(6):856-7. PubMed ID: 8750284
[No Abstract] [Full Text] [Related]
14. Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).
Safdar A; Singhal S; Mehta J
Cancer; 2004 Jun; 100(11):2456-61. PubMed ID: 15160352
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Byrne JL; Stainer C; Hyde H; Miflin G; Haynes AP; Bessell EM; Russell NH
Bone Marrow Transplant; 1998 Sep; 22(6):541-5. PubMed ID: 9758340
[TBL] [Abstract][Full Text] [Related]
16. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
[TBL] [Abstract][Full Text] [Related]
17. [Allogeneic peripheral blood stem cell transplantation].
Harada M
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1877-85. PubMed ID: 8978790
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic peripheral blood progenitor cell transplantation in solid tumors.
Ueno NT; Hortobagyi GN; Champlin RE
Cancer Treat Res; 1999; 101():133-56. PubMed ID: 10800648
[No Abstract] [Full Text] [Related]
19. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
Bishop MR; Hou JW; Wilson WH; Steinberg SM; Odom J; Castro K; Kasten-Sportes C; Gea-Banacloche J; Marchigiani D; Gress R; Fowler DH
Biol Blood Marrow Transplant; 2003 Mar; 9(3):162-9. PubMed ID: 12652466
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Lambertenghi-Deliliers G; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S40-6. PubMed ID: 8722334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
